Cognitive behavioral therapy in youth: An update

Psychiatric Annals

Volumn 41, Issue 4, 2011, Pages 226-231

  Kennard, Betsy D ^a   Mahoney, Jodi R ^a   Mayes, Taryn L ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79959235755     PISSN: 00485713     EISSN: None     Source Type: Journal    
DOI: 10.3928/00485713-20110325-06     Document Type: Article

References (38)

1. Birmaher B, Arbelaez C, Brent D. Course and outcome of child and adolescent major depressive disorder. Child Adolesc Psychiatr Clin N Am. 2002;11(3):619-637.
2. Lewinsohn PM, Clarke GN, Seeley JR, Rohde P. Major depression in community adolescents: age at onset, episode duration, and time to recurrence. J Am Acad Child Adolesc Psychiatry. 1994;33(6):809-818.
3. Lewinsohn PM, Rohde P, Seeley JR. Major depressive disorder in older adolescents: prevalence, risk factors, and clinical implications. Clin Psychol Rev. 1998;18(7):765-794.
4. Birmaher B, Brent D, the AACAP Work Group on Quality Issues. Practice parameter for the assessment and treatment of children and adolescents with depressive disorders. J Am Acad Child Adolesc Psychiatry. 2007;46(11):1503-1526.
5. Beck AT, Rush AJ, Shaw BF, Emery G. Cognitive Therapy of Depression. New York: NY; Guilford Press; 1979.
6. Clarke G, Lewinsohn P, Hops H. Leader's Manual for Adolescent Groups: Adolescent Coping with Depression Course. Portland: Kaiser Permanente; 1990: Available at: www.kpchr.org/public/acwd/ CWDA_manual.pdf. Accessed March 18, 2011.
7. Brent DA, Holder D, Kolko D, et al. A clinical psychotherapy trial for adolescent depression comparing cognitive, family, and supportive treatments. Arch Gen Psychiatry. 1997;54(9):877-885.
8. Rohde P, Feeny NC, Robins M. Characteristics and components of the TADS CBT approach. Cogn Behav Pract. 2005;12(2):186-197.
9. Weersing VR, Iyengar S, Kolko DJ, Birmaher B, Brent DA. Effectiveness of cognitive-behavioral therapy for adolescent depression: a benchmarking investigation. Behav Ther. 2006;37(1):36-48.
10. Weisz JR, McCarty CA, Valeri SM. Effects of psychotherapy for depression in children and adolescents: a meta-analysis. Psychol Bull. 2006;132(1):132-149.
11. David-Ferdon C, Kaslow NJ. Evidence-based psychosocial treatments for child and adolescent depression. J Clin Child Adolesc Psychol. 2008;37(1):62-104.
12. Rossello J, Bernal G, Rivera-Medina C. Individual and group CBT and IPT for Puerto Rican adolescents with depressive symptoms. Cult Divers Ethnic Minor Psychol. 2008;14(3):234-245.
13. Curry JF. Specific psychotherapies for childhood and adolescent depression. Soc Biol Psych. 2001;49(12):1091-1100.
14. Weersing VR, Brent DA. Cognitive behavioral therapy for depression in youth. Child Adolesc Psychiatr Clin N Am. 2006;15(4):939-957.
15. Compton SN, March JS, Brent D, Albano AM, Weersing VR, Curry J. Cognitive-behavioral psychotherapy for anxiety and depressive disorders in children and adolescents: an evidence-based medicine review. J Am Acad Child Adolesc Psychiatry. 2004;43(8):930-959.
16. Chambless DL, Hollon SD. Defining empirically supported therapies. J Consult Clin Psychol. 1998;66(1):7-18.
17. March J, Silva, S, Petrycki, S, et al. Treatment for Adolescents with Depression Study Team. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression. JAMA. 2004;292(7):807-820.
18. Brent D, Emslie G, Clarke G, et al. Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial. JAMA. 2008;299(8):901-913.
19. Clarke G, DeBar L, Lynch F, et al. A randomized effectiveness trial of brief cognitive-behavioral therapy for depressed adolescents receiving antidepressant medication. J Am Acad Child Adolesc Psychiatry. 2005;44(9):888-898.
20. Melvin GA, Tonge BJ, King NJ, Heyne D, Gordon MS, Klimkeit E. A comparison of cognitivebehavioral therapy, sertraline, and their combination for adolescent depression. J Am Acad Child Adolesc Psychiatry. 2006;45(10):1151-1161.
21. Goodyer I, Dubicka B, Wilkinson P, et al. Selective serotonin reuptake inhibitors (SSRIs) and routine specialist care with and without cognitive behaviour therapy in adolescents with major depression: randomised controlled trial. BMJ. 2007;335(7611):142.
22. U.S. Department of Health and Human Services NIH, National Institute of Mental Health. National Institute of Mental Health Strategic Plan (NIH Publication No. 08-6368. 2008.
23. Curry J, Rohde P, Simons A, et al; TADS Team. Predictors and moderators of acute outcome in the treatment for adolescents with depression study (TADS). J Am Acad Child Adolesc Psychiatry. 2006;45(12):1427-1439.
24. Asarnow JR, Emslie G, Clarke G, et al. Treatment of selective serotonin reuptake inhibitor-resistant depression in adolescents: predictors and moderators of treatment response. J Am Acad Child Adolesc Psychiatry. 2009;48(3):330-339.
25. Weersing VR, Rozenman M, Gonzalez A. Core components of therapy in youth: do we know what to disseminate? Behav Modif. 2009;33(1):24-47.
26. Kennard BD, Clarke GN, Weersing VR, et al. Effective components of TORDIA cognitivebehavioral therapy for adolescent depression: preliminary findings. J Consult Clin Psychol. 2009;77(6):1033-1041.
27. Kaufman NK, Rohde P, Seeley JR, Clarke GN, Stice E. Potential mediators of cognitive-behavioral therapy for adolescnets with comorbid major depression and conduct disorder. J Consult Clin Psychol. 2005;73(1):38-46.
28. Kennard BD, Emslie GJ, Mayes TL, Hughes JL. Relapse and recurrence in pediatric depression. Child Adolesc Psychiatr Clin N Am. 2006;15(4):1057-1079.
29. Emslie GJ, Kennard BD, Mayes TL, et al. Fluoxetine versus placebo in preventing relapse of major depression in children and adolescents. Am J Psychiatry. 2008;165(4):459-467.
30. Kennard BD, Silva SG, Vitiello B, et al. Remission and residual symptoms after short-term treatment in the treatment of adolescents with depression study (TADS). J Am Acad Child Adolesc Psychiatry. 2006;45(12):1404-1411.
31. Frank E, Prien RF, Jarrett RB, et al. Conceptualization and rationale for consensus definitions of terms in major depressive disorder: remission, recovery, relapse, and recurrence. Arch Gen Psychiatry. 1991;48(9):851-855.
32. Kennard BD, Silva SG, Tonev S, et al. Remission and recovery in the treatment for adolescents with depression study (TADS): acute and long-term outcomes. J Am Acad Child Adolesc Psychiatry. 2009;48(2):186-195.
33. Curry J, Silva S, Rohde P, et al. Recovery and recurrence following treatment for adolescent major depression. Arch Gen Psychiatry. 2011;62(3):263-269.
34. Fava G, Fabbri S, Sonino N. Residual symptoms in depression: an emerging therapeutic target. Prog Neuropsychopharmacol Biol Psychiatry. 2002;26(6):1019-1027.
35. Karp J, Buysse D, Houck P, et al. Relationship of variablity in residual symptoms with recurrence of major depressive disorder during maintenance treatment. Am J Psychiatry. 2004;161(10):1877-1884.
36. Clarke G, Rohde P, Lewinsohn P, et al. Cognitivebehavioral treatment of adolescent depression: efficacy of acute group treatment and booster sessions. J Am Acad Child Adolesc Psychiatry. 1999;38(3):272-279.
37. Kroll L, Harrington R, Jayson D, et al. Pilot study of continuation cognitive-behavioral therapy for major depression in adolescent psychiatric patients. J Am Acad Child Adolesc Psychiatry. 1996;35(9):1156-1161.
38. Kennard BD, Emslie GJ, Mayes TL, et al. Cognitive-behavioral therapy to prevent relapse in pediatric responders to pharmacotherapy for major depressive disorder. J Am Acad Child Adolesc Psychiatry. 2008;47(12):1395-1404.